Bio-Rad Laboratories, Inc., commonly known as BioRad, is a world-renowned American life sciences and clinical diagnostics company founded in 1952 by David and Alice Schwartz in a small cottage in Berkeley, California. With a 70-year legacy of innovation and commitment to advancing science, it has evolved into a global pioneer, headquartered in Hercules, California, USA. As a publicly traded company listed on the New York Stock Exchange under the ticker symbol "BIO" with a total market value of approximately $72.36 billion as of February 2026, BioRad empowers researchers, clinicians, and professionals worldwide with over 7,500 employees, operating in more than 35 countries and serving customers in 100+ nations.
Core Business and Market Leadership
BioRad focuses on two core business segments: life science research and clinical diagnostics, with a comprehensive portfolio covering instruments, reagents, software, and quality control solutions. It holds a leading position in global markets such as electrophoresis, PCR/qPCR, and clinical quality control, serving diverse sectors including academic research, biopharmaceuticals, food safety, and healthcare. In 2024, the company achieved annual sales of $2.6 billion, and its 2025 fourth-quarter revenue reached $6.93 billion with a year-on-year growth of 3.85%, reflecting its strong market competitiveness and stable development momentum.
Technological Innovation and Product Portfolio
Innovation has been the core driving force of BioRad’s long-term development, with continuous breakthroughs shaping the future of life sciences and diagnostics. Its diverse product portfolio focuses on four core categories:
-
Life Science Research Solutions: Flagship products include electrophoresis systems, PCR/qPCR instruments, and protein purification tools, such as the Gene Pulser™ electroporation system and Criterion Stain-Free™ gel imaging system, which simplify workflows and accelerate scientific discoveries in genomics and proteomics.
-
Clinical Diagnostics: Solutions for diabetes monitoring, infectious disease detection, and hemoglobin analysis, including the D-10™ hemoglobin testing system and high-sensitivity NSCLC mutation detection kits based on ddPCR™ technology, supporting accurate diagnosis and patient management.
-
Quality Control Solutions: Products like InteliQ Load-and-Go Quality Controls, which are ready-to-use and barcoded, optimizing laboratory workflows and ensuring result reliability for clinical and industrial labs.
-
Educational Tools: Through its Biotechnology Explorer™ program, BioRad provides hands-on STEM training resources for high school and college students, fostering the next generation of scientific talent.
Notably, BioRad’s electrophoresis and PCR technologies have become industry standards, widely adopted by research institutions and laboratories worldwide for their reliability and performance.
Global Presence and Localization
BioRad maintains a robust global network with manufacturing facilities, R&D centers, and sales offices across the Americas, Europe, Middle East, Africa, and Asia Pacific. In China, a key overseas market, it has established product and manufacturing hubs, including a facility in Shanghai, and a comprehensive service system to adapt to local needs, supporting scientific research and healthcare development in the region.
Commitment to Society and Sustainability
BioRad integrates sustainability and social responsibility into its core operations, focusing on eco-friendly product design and global scientific education. It actively cooperates with academic institutions worldwide to advance technological innovation and supports public health initiatives by providing reliable diagnostic tools for disease prevention and control, embodying its mission of "empowering science to improve human health and well-being."
In summary, BioRad Laboratories stands as a trusted benchmark in the life sciences and clinical diagnostics industry, blending a 70-year heritage of innovation with customer-centric solutions. With its comprehensive product portfolio, global service network, and commitment to excellence, BioRad continues to empower scientific breakthroughs and improve healthcare outcomes worldwide.
